May 16, 2017

BioUpper's final pitch at the Ministry of Health: they talk about us!

Read more »
May 10, 2017

FINAL PITCH OF THE SECOND EDITION OF BIOUPPER AT THE MINISTRY OF HEALTH

Read more »
May 8, 2017

BioUpper: Minister Lorenzin rewarded the winners of the second edition. From Novartis and the Cariplo Foundation, three € 50,000 vouchers

Read more »
May 2, 2017

BioUpper 2017: the grand finale at the Ministry of Health

On next May 8, the prestigious institutional venue will host, for the first time, the awarding of the three winners.

Read more »
Apr 3, 2017

BioUpper on MilanoFinanza : speaking about smart working.

Read more »
Feb 16-17, 2017

Innovation Day II: meeting with the experts on February 16 and 17, at Cariplo Factory

Second “pit stop” for the ten finalist teams taking part in the Acceleration Program of BioUpper 2017.

Read more »
Feb 02, 2017

BioUpper in the news: talent and innovation

Read more »
Jan 26, 2017

THE ACCELERATION PROGRAM ABOUT TO START
Thursday, January 26 - Cariplo Factory

For the 10 finalist teams, selected during the elevator pitch of last January 10, the Acceleration Program – ending on April 20, 2017 – is about to begin.


The Acceleration Program is the most important step for the candidate start-uppers, who will have the opportunity to prepare themselves in the best possible way for the final pitch and thus compete for one of the three final € 50,000 prizes.


Lasting ten weeks, the Acceleration Program is calibrated on each business plan, based on the life cycle of the product/service proposed. Each finalist, in fact, will be coached by a multidisciplinary team – formed by business angels, industry vertical professionals and senior PwC consultants – which will support them in the development of their idea and in the organization of an effective business plan.

 


Jan 11, 2017

BioUpper: the 10 finalist projects have been selected

  • Out of the 151 candidate projects, 17 teams were selected which, last December, participated in a training week aimed at translating ideas into a business model
  • On January 10, the 17 teams competed in front of the jury: 10 are the finalists participating in the acceleration phase
  • During the final of April 12, the jury will select the three best projects, each of which will win a € 50,000 voucher to be invested in the launch of the startup

Milan, January 11, 2017 – The 10 business ideas which will enter the second phase of BioUpper – the initiative sponsored by Novartis and Fondazione Cariplo in support of young talents who wish to create a startup in the field of life sciences – have been selected.


In its second year, BioUpper is organized in collaboration withPoliHub, the startup district & incubator of the Fondazione Politecnico di Milano, and with the scientific validation of Humanitas, hospital group and cutting-edge, internationally renowned research facility.


The program has collected 30% more applications (151) than in 2015; a subsequent phase saw the identification of 17 teams, which participated in the training week, a path of education and debate with industry professionals, tutors and business angels. Yesterday in Milan the elevator pitch was held, a competition during which the 17 teams from all over Italy submitted their projects to the jury.


The 10 ideas selected at this stage are thus shared among two of the application scopes provided for by the competition notice: medical science-oriented biotechnologies – BTeam, Kyme, Postbiotica – and medical devices – Golgi, Holey, Newrosparks, Pd-Watch, Probiomedica, Watch-me, Wound Viewer .


70% of the teams are characterized by a female presence, and the average age of the candidate startuppers is 30/35. One of the ten teams, Watch-Me, was able to access BioUpper thanks to the wild card that the program offered to Hacking Health, an international movement that promotes (also in Italy) innovation, motivating the co-creation between clinical research and academia.


Already in its second year, BioUpper is proving to be a solid reality for the young Italian startuppers; this initiative, in fact, is highlighting a credible path supporting innovation in the health sector” - stated Georg Schroeckenfuchs, CEO and Country President, Novartis Italia. “The credit goes to a formula which enhances the content and quality of the ideas proposed, without losing contact with their real potential in terms of business. This formula has been acknowledged also by the market, which rewarded several projects from the first edition. We wish the same success to the 10 new ideas that are now reaching the decisive phase of BioUpper 2017”.


We are proud to be hosting in Cariplo Factory the second edition of BioUpper, a project that is proving increasingly competitive added Carlo Mango, Director of the Scientific Research Area of the Cariplo Foundation . “The new hub of our Foundation aims to become the reference point for the creation of open innovation projects and for the promotion of young talents. With BioUpper we showed that profit–nonprofit cooperation has an enormous potential, so much so that – after only one year of life – this project has become a model for other companies wishing to support young entrepreneurship and the creation of innovative startups”.


The pitch session saw the 17 teams explain their projects in two phases: 6 initial minutes for the presentation of the team and the research work carried out, and 6 more minutes of debate with the jury, which was composed of representatives of the business, scientific and institutional sectors, active in the development of new businesses and experts in the areas of support to entrepreneurship.


The two representatives of the Institutions – Mattia Corbetta, from the General Directorate for Industrial Policy, Competitiveness and SMEs of the Ministry of Economic Development, and Nando Minella, Chief Technical Advisor of the Minister of Health – emphasized their support to research and their appreciation of BioUpper.


In recent years we are seeing an actual revolution in the world of life sciences, that is becoming increasingly digital ”, – commented Minella – “ and the candidate startuppers who participate in this program are the main actors of this change. In this context, BioUpper plays an important role as facilitator and accelerator of the industrialization processes of projects that affect the health of patients, often improving their living conditions if not, indeed, curing them from diseases so far incurable ”.


BioUpper pursues purposes which are consistent with the objectives that the Ministry of Economic Development set in recent years, starting from the approval of the national policy on innovative startups ”, said Corbetta. “ Innovation, talent and human capital are the paradigms that we want to promote, through measures such as the tax credit for research and development, the Patent Box and the hyper-amortization on the investment in innovation, all of which also characterized the recent Budget Law. In this context, BioUpper is an initiative of great value, because it clearly exemplifies our focus ”.


The elevator pitch was held in Cariplo Factory, an innovative reality created in Milan – thanks to the efforts of Fondazione Cariplo – to promote the exchange among startuppers and in which participants will be able to find an additional support for improving international strategies and the capital they need to grow, through the ecosystem built with technological partners, Venture Capital funds and large corporations.


The 10 selected proposals will access the ten-week Acceleration Program (from January 26 to April 20): a custom-built pathway, aimed at setting and make effective the “go-to-market” phase, i.e. the market entry of the project. The program will be calibrated on each business idea, based on the life cycle of the product or service offered. Each project will be followed by a multidisciplinary team composed of business angels, vertical industry professionals and senior advisors, together with the advisory for the structuring of effective business plans, care of PwC.


Once completed this last stage, each team will be called to present the results obtained in the pitch session on next May 8. Each of the top three will receive a contribution of € 50,000, which will allow them to make use, in a custom and flexible way, of further specialized advice and services and activities for the development of their business plan, in order to facilitate and make effective the market access path.


The 10 ideas selected, which will access the Acceleration Program


BTeam (Lazio) offers bromothymol, a new, powerful antibacterial, developed through a low-cost and environmentally sustainable production process, which has proven to be an effective active ingredient both for personal hygiene and for the disinfection of all surfaces.


Golgi (Emilia Romagna) is the first 3D printer that enables research centers to print three-dimensional biological tissues, to be used in pharmacological and biomedical research and in cosmetics, allowing to customize the in vitro testing phase, and therefore dramatically lower its costs.


Holey (Lazio) is the first platform that allows healthcare organizations to 3D print orthopedic braces, ensuring a significant reduction in costs compared to the commercial braces, and reducing complications with regard to traditional plaster casts. Patients thus can use customizable devices, which are also anti-allergic and water resistant.


Kyme (Campania) applies nanotechnology to medical diagnostics in order to improve the contrast media currently used clinically, allowing an early and more accurate identification of the diseases. Thanks to the increased efficacy of the formulation, it is possible to increase the MRI images contrast, reducing the amount of injectable product and, consequently, its toxicity.


Newrosparks (Emilia Romagna) is the first system that helps quit smoking by means of a wearable device that increases the ability to control nicotine addiction.


PD-Watch (Basilicata) provides a continuous and non-invasive monitoring of the tremor caused by Parkinson’s disease, allowing the specialist to support the early diagnosis and to better control – remotely – the evolution of the disease.


Postbiotica (Lombardia) develops novel therapies based on bacteria derivatives – obtained through an innovative method of fermentation – to prevent and organically treat a wide spectrum of inflammatory conditions: from allergic reactions to chronic bowel and urogenital tract diseases.


Probiomedica (Toscana) offers an innovative phototherapy for the treatment of Helicobacter pylori infection, designed for antibiotic-resistant patients, who account for about 25% of the total. The device is an ingestible capsule that, once in the gastric tract, eradicates the bacterium through the emission of light, thus avoiding the side effects of the current antibiotic therapy.


Watch-me (Lombardia) is a device for the care of children with cognitive retardation: it allows to support the rehabilitative intervention at home, actively involving parents.


Wound Viewer (Piemonte) is the first 3D system for the monitoring and automatic evaluation of skin ulcers, affecting 2% of the world population. An artificial intelligence algorithm independently processes the data from the device and returns the objective parameters necessary to support the specialists in their appropriate therapeutic choice. The use of Wound Viewer therefore significantly reduces the recovery time and, consequently, the hospitalization time and costs.

 

For further information:

Rossana Bruno - Novartis Farma
Tel. 347 8703671
Email. rossana.bruno@novartis.com


Emanuela Murari - PoliHub
Tel. 339 2801017
Email: emanuela.murari@fondazione.polimi.it


Bianca Longoni - Fondazione Cariplo
Tel. 02 6239405
Email.biancalongoni@fondazionecariplo.it


Federica Gramegna – Comin & Partners 
Tel. 338 2229807
Email. federica.gramegna@cominandpartners.com

 


Jan 10, 2017

BIOUPPER ELEVATOR PITCH
Tuesday, January 10, 9:30am – 5:30pm
Cariplo Factory, Via Bergognone 34, corner of Via Tortona, Milan

This year the BioUpper Elevator Pitch – which will take place at the Cariplo Factory will see the competition between the 17 teams which participated in the Training Week , seven days of lessons dedicated to the creation of business models and development plans, to the techniques of presentation of projects to investors and to debating workshops and meetings with business angels.

The challenge for the teams will be to present and sell in the best possible way their idea in order to convince – in just 12 minutes (6 minutes for the presentation and 6 minutes for the Q&A session) – the jury, which is composed of representatives of the business, Research, financial and institutional sectors, active in the development of new ventures and experts in the areas of support to entrepreneurship.

Jurors

LUCIANO BAIELLI – General Director Cogentech

DANNY BAR ZOHAR – Chief Scientific Officer Novartis Farma Italia

ALESSIO BEVERINA – Co-founder and General Partner Panakès Partners

MATTEO BONFANTI – Senior Investment Manager Quadrivio Capital SGR, Venture Capital Area

MATTIA CORBETTA – General Directorate Ministry of Economic Development

PAOLO CREMASCOLI – Venture Partner Innogest

GIUSEPPE DI PIAZZA – Director Corriere Innovazione

STEFANO MAINETTI – Managing Director PoliHub Fondazione Politecnico

CARLO MANGO – Director Scientific Research Fondazione Cariplo

ALBERTO MANTOVANI – Scientific Director Istituto Clinico Humanitas

NANDO MINNELLA – Chief Technical Secretariat Minister of Health

GEORG SCHROECKENFUCHS – CEO & Country President Novartis Italia

PAOLO D. SIVIERO – Senior Advisor and Fund manager Principia III


Throughout the day, the members of the jury will evaluate the 17 ideas, in order to select the best ten, which will access the acceleration phase (Acceleration Program) from January 26 to April 6, 2016, after which 3 winning team will be chosen, each of which will receive an economic contribution of € 50,000.

 


Dic 12, 2016

BioUpper: The training week for aspiring startuppers in the field of life sciences is about to start

  • The BioUpper training week will be held in Milan, from today to December 17
  • Seventeen teams selected among 151 candidates; Lombardia the most represented region
  • The objective is to translate an idea into a competitive project, capable of attracting investors
  • On January 10 the jury will select the 10 teams who will have access to the two-month Acceleration Program

Milan, December, 2016 – The BioUpper training week – the program promoted by Novartis Italia and Fondazione Cariplo in support of young talents who want to create a business in the field of life sciences – starts today; this year the initiative, in its second edition, collected 151 applications, 30% more than in 2015, confirming the validity of its innovative formula.

The teams selected by BioUpper, in collaboration with PoliHub, the incubator of the Fondazione Politecnico di Milano, are 17: until December 17, they will have the opportunity to experience one of the most challenging stages of the program. During the training week, in fact, aspiring startuppers will “clash” straight away with the real needs of the market, in order to fully get into the spirit of the initiative.

Participants come from 9 Italian regions: geographically, the most represented area is, like last year, Lombardy, with five projects selected. Emilia Romagna, Lazio, Piemonte and Toscana follow, respectively, with two projects each. Also present are Basilicata, Campania, Liguria and Veneto, with 1 project each. Three of these ideas belong to the biotechnology sector, ten to medical devices and four to patient-oriented services.

In addition, as announced, two of the selected team, have recently participated in Hacking Health, an international movement committed in the field of health and care, which promotes – in Italy as well – innovation, through the co-creation between clinical research and academia.

The choice was made according to specific criteria: satisfaction of a need/necessity; innovativeness of the solution; technological impact; technical feasibility and economic viability; quality and skills of the team; scalability/replicability: all key elements for the evaluation by potential investors, according to whom any life science project must also include managerial skills, in order to survive in the market.

The training course aims to help aspiring startupper to present their ideas in a more attractive way, preparing them for the moment they will have to display their projects in front of business angels, who will judge them on the basis of economic indicators often unknown to those who have only ever dealt with the research world.

During the training week, therefore, the 17 teams will attend lessons dedicated to the creation of the business model and the development plan, techniques for the presentation of projects to entrepreneurs, debating workshops and ad hoc meetings, in order to best prepare for the final presentation before the Jury, scheduled for January 10.

After the presentation, the Jury – which is made of representatives from the institutions and the industry, research and finance sectors active in the development of new businesses – will select the 10 proposals that will enter the two-month Acceleration Program.

The objective of the Acceleration Program is to support the teams in preparing and making effective the “go-to-market” phase, i.e. the entry of the project into the market. The program is tailored to each business idea, based on the life cycle of the proposed product/service, and consists of: laboratory work, incubation time, guided tours to companies and districts, also foreign.

This stage will take place in Cariplo Factory, an innovative reality – created through the efforts of the Fondazione Cariplo in Milan to promote the exchange among startuppers – in which participants will be able to find a support to further improve their international strategies and find the money necessary for growth, through the ecosystem created with technology partners, Venture Capital funds and large corporations.

Once completed this last step, each team will be called to present their results. The top three will each receive a € 50,000 contribution, which will allow them to take advantage of customized consulting, services and activities for the further development of their business idea, so as to facilitate the access to the market.

 

Per maggiori informazioni:

Rossana Bruno - Novartis Farma
Tel. 347 8703671
Email. rossana.bruno@novartis.com


Emanuela Murari - PoliHub
Tel. 339 2801017
Email: emanuela.murari@fondazione.polimi.it


Bianca Longoni - Fondazione Cariplo
Tel. 02 6239405
Email.biancalongoni@fondazionecariplo.it


Federica Gramegna – Comin & Partners 
Tel. 338 2229807
Email. federica.gramegna@cominandpartners.com

 


Dic 5, 2016

HERE ARE THE TEAMS SELECTED FOR THE TRAINING WEEK

The jury concluded the evaluation of the 151 candidate projects for the second edition of BioUpper and selected the best ideas, that will have access to the Training Week.

Three projects in the field of biotechnology, eleven in the medical devices sector and five for patient-oriented services will thus access the Training Week, which will be held December 12 to 17 in Milan. Among the selected projects, six are from Lombardy, two each from Emilia Romagna, Lazio, Piemonte and Toscana, one each from Abruzzo, Basilicata, Campania, Liguria and Veneto. Below is the list of the selected projects:

BIOTECHNOLOGY

Beta-Stop
Field: Biotechnology
Region: Toscana

Short description: Beta-Stop is a kit that uses innovative nanosensors for the early diagnosis of neurodegenerative disorders, such as Parkinson’s and Alzheimer’s. In addition, in the future the same system could become an innovative therapy in itself.


BTeam
Field: Biotechnology
Region: Lazio

Short description: BTeam offers bromothymol, a new, powerful antibacterial, developed through a low-cost and environmentally sustainable production process, which has proven to be an effective active ingredient both for personal hygiene and for the disinfection of all surfaces.


Postbiotica
Field: Biotechnology
Region: Lombardia

Short description: Postbiotica develops novel therapies based on bacteria derivatives – obtained through an innovative method of fermentation – to prevent and organically treat a wide spectrum of inflammatory conditions: from allergic reactions to chronic bowel and urogenital tract diseases.


MEDICAL DEVICES

Woundviewer
Field: Medical devices
Region: Piemonte

Short description: Wound Viewer is the first 3D system for the monitoring and automatic evaluation of skin ulcers, affecting 2% of the world population. An artificial intelligence algorithm independently processes the data from the device and returns the objective parameters necessary to support the specialists in their appropriate therapeutic choice. The use of WoundViewer therefore significantly reduces the recovery time and, consequently, the hospitalization time and costs.


Holey
Field: Medical devices
Region: Lazio

Short description: Holey is the first platform that allows healthcare organizations to 3D print orthopedic braces, ensuring a significant reduction in costs compared to the commercial braces, and reducing complications with regard to traditional plaster casts. Patients thus can use customizable devices, which are also anti-allergic and water resistant.


Pre-Op
Field: Medical devices
Region: Lombardia

Short description: Pre-Op guides the surgeon in the preoperative planning and during surgery, helping the specialist – through a 3D model of the patient – to accurately and immediately visualize the target anatomy, thus reducing errors, waste of materials and costs borne by the NHS. This innovative system also supports the specialist in explaining the surgery to the patients themselves and to the training doctors.


HeartWatch
Field: Medical devices
Region: Lombardia

Short description: HeartWatch is an innovative self-screening service – designed for consumers attentive to their lifestyle – which in 2 minutes can detect any silent cardiac and respiratory diseases. The service works through an ordinary video camera (from PC or smartphone) that, framing the user’s face, detects any abnormalities in the cardiac and respiratory signal and, if necessary, suggests a specialist examination.


Bioprinter Golgi
Field: Medical devices
Region: Emilia Romagna

Short description: Golgi is the first 3D printer that enables research centers to print three-dimensional biological tissues, to be used in pharmacological and biomedical research and in cosmetics, allowing to customize the in vitro testing phase, and therefore dramatically lower its costs.


Probiomedica
Field: Medical devices
Region: Toscana

Short description: Probiomedica offers an innovative phototherapy for the treatment of Helicobacter pylori infection, designed for antibiotic-resistant patients, who account for about 25% of the total. The device is an ingestible capsule that, once in the gastric tract, eradicates the bacterium through the emission of light, thus avoiding the side effects of the current antibiotic therapy.


Newrosparks
Field: Medical devices
Region: Emilia Romagna

Short description: Newrosparks is the first system that helps quit smoking by means of a wearable device that increases the ability to control nicotine addiction.


Kyme
Field: Medical devices
Region: Campania

Short description: Kyme applies nanotechnology to medical diagnostics in order to improve the contrast media currently used clinically, allowing an early and more accurate identification of the diseases. Thanks to the increased efficacy of the formulation, it is possible to increase the MRI images contrast, reducing the amount of injectable product and, consequently, its toxicity.


PD-Watch
Field: Medical devices
Region: Basilicata

Short description: PD-Watch provides a continuous and non-invasive monitoring of the tremor caused by Parkinson’s disease, allowing the specialist to support the early diagnosis and to better control – remotely – the evolution of the disease.


Alexia
Field: Medical devices
Region: Veneto

Short description: Considering the benefits of the water labor for the woman (reduction of pain, medicalization, complications), Alexia is an innovative system aimed at supporting hospitals in the management of water labor and birth: it ensures both the physiology of childbirth and the management of the obstetric emergency with the highest safety standards.


PATIENT-ORIENTED SERVICES

H-Maps
Field: Patient-oriented services
Region: Liguria

Short description: H-Maps is the first app that helps cancer patients to find their way through the disease by offering clear, precise and validated instructions on the therapeutic journey they are about to make. Infographic maps accompany the users along their entire healthcare path, with descriptions and information about coping in full awareness with the various “stages” of the journey (visits, examinations, treatments) and to also find their bearings within the various hospitals: not to lose their way, even when the road is uphill.


AroundCare
Field: Patient-oriented services
Region: Piemonte

Short description: AroundCare is an innovative digital platform that connects physiotherapists and osteopaths with people seeking home assistance, allowing patients to select the HCP most suitable for their needs. The service stands out because is an interactive system, that supports the patient from the choice of the HCP until the stages following the latter’s service.


Kit
Field: Patient-oriented services
Region: Lombardia

Short description: Kit is a service offered by the hospital, which provides the patients with the goods and services necessary for their hospitalization, anticipating their needs. It is an intelligent digital tool that communicates via chat with the patient and that is especially useful in case of emergency or unexpected hospitalization.


Watchme
Field: Patient-oriented services
Region: Lombardia

Short description: Watch-me is a device for the care of children with mental retardation: it allows to support the cognitive rehabilitation of children with neurodevelopmental disorders at their home, actively involving parents.



Feb 03, 2016

The Acceleration Programme Ready to Start

Friday, February 5 - PoliHub, Via Durando 38A

The acceleration programme is about to start: it will be run from February 5 to March 31, 2016.

The Acceleration Programme is the last step before the final pitch for the three best startup projects, that will be awarded a € 50,000 voucher each.

The acceleration programme is tailored to each business plan, based on the life cycle of the product/service proposed. The Acceleration Programme develops the business of the selected projects through the interaction with external stakeholders – such as tutors, temporary managers, representatives of universities and incubators – with the aim of finalizing the go-to-market strategy.

The 10 finalist ideas:


  1. Beating heart on a chip
    Category: Biotechnology
    Region: Lombardy
  2. Brief description: Beating heart on a chip is a biotech device that can generate functional human cardiac micro-tissues for the development of drugs.


  3. BrainControl
    Category: Digital devices
    Region: Tuscany
  4. Brief description: BrainControl is a device that gives people with physical and communication disabilities the ability to control with their "minds" (technically Brain-Computer Interface) the tools of assistive technologies (i.e. domotics devices, electric wheelchairs).


  5. EvarPlanning
    Category: Digital devices
    Region: Lombardy
  6. Brief description: EVARplanning is an innovative computerized system, intended for vascular specialists, for the planning and rendering of the endo-prosthetic aorta implant.


  7. FluoMagneto
    Category: Biotechnology
    Region: Liguria
  8. Brief description: FluoMagneto offers an alternative to chemotherapy in the treatment of solid tumors, through the use of magnetic nanoparticles, which release the drug at the tumor site through the action of an alternating magnetic field.


  9. Panoxyvir
    Category: Biotechnology
    Region: Piedmont
  10. Brief description: Panoxyvir is an antiviral nasal spray able to prevent and treat the common cold, through the innovative use of oxysterols, physiological molecules derived from the enzymatic oxidation of cholesterol.


  11. Math2Ward
    Category: Digital devices
    Region: Lombardy
  12. Brief description: Math2Ward is a platform that uses specific mathematical algorithms to provide in real time cardiologists and cardiovascular surgeons with a "patient-specific" evaluation of the abdominal aortic aneurysm rupture risk and an indication of the devices to be used in case of intervention.


  13. One4Two
    Category: Digital devices
    Region: Campania
  14. Brief description: One4Two is a laboratory diagnostic kit that allows to identify in a single analytical step the genetic and chromosomal variants related to infertility.


  15. uSTEM
    Category: Biotechnology
    Region: Veneto
  16. Brief description: uSTEM has developed an innovative technology capable of generating patient-specific stem cells, useful for the development of new drugs and personalized therapies.


  17. SIENA Imaging
    Category: Digital devices
    Region: Tuscany
  18. Brief description: SIENA Imaging is a service of centralized analysis of magnetic resonance images of the brain, offering to neurologists and neuroradiologists accurate biomarkers of both diffuse and focal brain damage.


  19. WRAP
    Category: Biotechnology
    Region: Emilia Romagna
  20. Brief description: WRAP uses patented materials and the 3D print technology to produce active scaffolds based on chitosan or multi-polymer, effective in the treatment of chronic wounds or surgical procedures.


Nov 10, 2015

The BioUpper Programme



Nov 10, 2015

Tuesday November 10 - Italian Corporate Venture Forum Torino
BioUpper presents at the Gran Prix of the Italian Start Ups
The event for the promotion and development of the regional and national entrepreneurship
#ICVF2015

Oct 26, 2015

The deadline to submit the applications has been extended to Friday November 20 at 23.59

Oct 16, 2015

Wednesday October 21 from 11:00

BioUpper Event

Sala Arena di PoliHub (via Durando 39, Milano)

To attend please fill the registration form

Click here to follow the live streaming of the event

Do you have an innovative idea in the field of Life Science and you are looking for support to make it happen?

PARTECIPATE
with your project